US Patent 10441544 Extended release pharmaceutical formulation
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+159 characters)
Article
Patent abstract
The invention provides an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.
Edits on 3 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Natalie June Medlicott0
Paul William Glue0
Peter William Surman0
Edits on 24 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Oct, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
104415440
Date of Patent
October 15, 2019
0Patent Application Number
157286950
Date Filed
October 10, 2017
0Patent Citations Received
Patent Primary Examiner
Golden AI
Infobox
Patent Citations Received
Edits on 23 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 31 Aug, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 29 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10441544 Extended release pharmaceutical formulation
Infobox
Is a
Patent jurisdiction
Patent number
10441544
Date of patent
October 15, 2019
Patent application number
15728695
Date Filed
October 10, 2017
Patent primary examiner
Find more entities like US Patent 10441544 Extended release pharmaceutical formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.